Therapeutic Modalities | Whitepapers & Reports
Axion Biosystems: Antibody-dependent Cellular Cytotoxicity of Natural Killer Cells
06 April 2023
Trastuzumab promotes natural killer cell activation through antibody-dependent cellular cytotoxicity (ADCC).
Related Resources
Related Online Activities
Join the conversation with our upcoming Monthly Science Exchanges and Webinars:Subscribe to our newsletter
Sign up for our monthly Newsletter to keep up with all things Immuno